Cite
HARVARD Citation
Huizinga, T. et al. (n.d.). SAT0210 First-in-Patient Study of Namilumab, an Anti-GM-CSF Monoclonal Antibody, in Active Rheumatoid Arthritis: Results of the Priora Phase IB Study. Annals of the rheumatic diseases. p. 733. [Online].